Vimarsana
Biggest News Aggregation in the World

Page 14 - Strides Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Strides Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Strides Pharma Today - Breaking & Trending Today

Nifty, Sensex Under Pressure - Weekly Closing Report - Vimarsana News

Nifty, Sensex Under Pressure - Weekly Closing Report

After a strong rally of eight days, the market came under pressure on Friday.

Stock Market Updates: Sensex Rises 50 pts, Nifty Near 19,400; HDFC Twins Drop 2% - Vimarsana News

Stock Market Updates: Sensex Rises 50 pts, Nifty Near 19,400; HDFC Twins Drop 2%

HDFC and HDFC Bank led losses on the Sensex, shlipping 2 per cent each. Wipro, NTPC, Eicher Motors were the other frontline losers.

Source: news18.com
Strides Pharma sinks after subsidiary plans to divest manufacturing plant - Vimarsana News

Strides Pharma sinks after subsidiary plans to divest manufacturing plant

The manufacturing unit has a potential for future expansion up to a further 20,000 litres of biologics drug substance manufacturing capacity.

Top gainers, losers today; HDFC twins, Maruti Suzuki, Bajaj Auto, Tech Mahindra; check full list here - Vimarsana News

Top gainers, losers today; HDFC twins, Maruti Suzuki, Bajaj Auto, Tech Mahindra; check full list here

Indian markets ended mixed due to global trends and moderation in service PMI data. Sensex ended slightly down while Nifty 50 ended slightly up. Bank Nifty settled lower and India's volatility index surged.

Nifty, Sensex May Give Up Some Gains - Wednesday Closing Report - Vimarsana News

Nifty, Sensex May Give Up Some Gains - Wednesday Closing Report

On Wednesday, 1966 stocks advanced, 1527 declined and 133 remained unchanged on the Bombay Stock Exchange (BSE), with an advance decline ratio of 1.29 indicating a positive closing of stocks in broader markets. Due to the recent upswing, the market was in an overbought area, therefore selective profit-taking was anticipated. For a brief period, the domestic market's surge was hampered by global concerns and moderate Service PMI data. Global investors' willingness to take on risk was put to the test by escalating trade tensions between the US and China and the uncertainty surrounding the forthc...